mutations provided The point that, as defined under, CLL therapy is predicated around the existence or absence of those mutations. The present consensus is the fact that, besides clonal mutations, subclonal mutations having a variant allelic frequency starting from 5 to 10% (and as a consequence below the brink of detection by common molecular stra